In addition, bendamustine plus Flu was found to be more effective than bendamustine or Cy/Flu alone in CD30 CAR T cell therapy for patients with R/R Hodgkin lymphoma (HL) (43, 44). This evidence concerns the gene TNFRSF8 and Hodgkins lymphoma.